Philip Tsai - 17 Jun 2024 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
Chief Technology Officer
Signature
/s/ Sandra Stoneman, Attorney-in-Fact
Issuer symbol
IMNM
Transactions as of
17 Jun 2024
Net transactions value
$0
Form type
4
Filing time
18 Jun 2024, 21:08:29 UTC
Next filing
25 Nov 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMNM Stock option (right to buy) Award $0 +250,000 $0.000000 250,000 17 Jun 2024 Common Stock 250,000 $13.15 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the options vest on June 17, 2025, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.